Calgary’s Orpyx Medical Technologies has launched next-generation sensory insoles to proactively monitor and prevent diabetic foot complications. The wireless insoles track plantar pressure, temperature, and activity, syncing automatically to a secure cloud. Backed by clinical studies, the technology has reduced ulcer recurrence by 86% and healthcare costs by 70%.
Patients are supported by dedicated nurses for coaching and adherence. With foot issues accounting for over $80 billion in U.S. diabetes care, Orpyx offers a scalable solution aligned with value-based care. CEO Dr. Breanne Everett says the goal is to keep people healthy and out of hospitals through early intervention.
Want to know more? Check out the source code on Calgary.tech.